Literature DB >> 34105993

Clinical Laboratory Biosafety Gaps: Lessons Learned from Past Outbreaks Reveal a Path to a Safer Future.

Nancy E Cornish1, Nancy L Anderson1, Diego G Arambula1, Matthew J Arduino2, Andrew Bryan3, Nancy C Burton4, Bin Chen1, Beverly A Dickson5, Judith G Giri6, Natasha K Griffith7, Michael A Pentella8, Reynolds M Salerno1, Paramjit Sandhu1, James W Snyder9, Christopher A Tormey10,11, Elizabeth A Wagar12, Elizabeth G Weirich1, Sheldon Campbell10,11.   

Abstract

Patient care and public health require timely, reliable laboratory testing. However, clinical laboratory professionals rarely know whether patient specimens contain infectious agents, making ensuring biosafety while performing testing procedures challenging. The importance of biosafety in clinical laboratories was highlighted during the 2014 Ebola outbreak, where concerns about biosafety resulted in delayed diagnoses and contributed to patient deaths. This review is a collaboration between subject matter experts from large and small laboratories and the federal government to evaluate the capability of clinical laboratories to manage biosafety risks and safely test patient specimens. We discuss the complexity of clinical laboratories, including anatomic pathology, and describe how applying current biosafety guidance may be difficult as these guidelines, largely based on practices in research laboratories, do not always correspond to the unique clinical laboratory environments and their specialized equipment and processes. We retrospectively describe the biosafety gaps and opportunities for improvement in the areas of risk assessment and management; automated and manual laboratory disciplines; specimen collection, processing, and storage; test utilization; equipment and instrumentation safety; disinfection practices; personal protective equipment; waste management; laboratory personnel training and competency assessment; accreditation processes; and ethical guidance. Also addressed are the unique biosafety challenges successfully handled by a Texas community hospital clinical laboratory that performed testing for patients with Ebola without a formal biocontainment unit. The gaps in knowledge and practices identified in previous and ongoing outbreaks demonstrate the need for collaborative, comprehensive solutions to improve clinical laboratory biosafety and to better combat future emerging infectious disease outbreaks.

Entities:  

Keywords:  biosafety; clinical laboratories; disinfection; ethics; laboratory equipment; laboratory testing; personal protective equipment; risk assessment; specimen collection and transport; waste management

Mesh:

Year:  2021        PMID: 34105993      PMCID: PMC8262806          DOI: 10.1128/CMR.00126-18

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   50.129


  147 in total

1.  Biosafety Training and Incident-reporting Practices in the United States: A 2008 Survey of Biosafety Professionals.

Authors:  Allison T Chamberlain; Louann C Burnett; Jennifer P King; Ellen S Whitney; Sean G Kaufman; Ruth L Berkelman
Journal:  Appl Biosaf       Date:  2009

2.  Bacterial and fungal infections among diagnostic laboratory workers: evaluating the risks.

Authors:  Ellen Jo Baron; J Michael Miller
Journal:  Diagn Microbiol Infect Dis       Date:  2007-11-08       Impact factor: 2.803

3.  Guidelines on good clinical laboratory practice: bridging operations between research and clinical research laboratories.

Authors:  J Ezzelle; I R Rodriguez-Chavez; J M Darden; M Stirewalt; N Kunwar; R Hitchcock; T Walter; M P D'Souza
Journal:  J Pharm Biomed Anal       Date:  2007-10-13       Impact factor: 3.935

4.  Medical waste treatment and disposal methods used by hospitals in Oregon, Washington, and Idaho.

Authors:  P Klangsin; A K Harding
Journal:  J Air Waste Manag Assoc       Date:  1998-06       Impact factor: 2.235

5.  Competency Guidelines for Public Health Laboratory Professionals: CDC and the Association of Public Health Laboratories.

Authors:  Renée Ned-Sykes; Catherine Johnson; John C Ridderhof; Eva Perlman; Anne Pollock; John M DeBoy
Journal:  MMWR Suppl       Date:  2015-05-15

6.  The effect of storage conditions on sample stability in the routine clinical laboratory.

Authors:  Rebecca L Kift; Christopher Byrne; Richard Liversidge; Fiona Babbington; Catherine Knox; Jeff Binns; Julian H Barth
Journal:  Ann Clin Biochem       Date:  2015-03-16       Impact factor: 2.057

7.  Sample Type and Storage Conditions Affect Calprotectin Measurements in Blood.

Authors:  Lise Pedersen; Erling Birkemose; Charlotte Gils; Sara Safi; Mads Nybo
Journal:  J Appl Lab Med       Date:  2018-05-01

8.  Infectious Disease Physicians' Perceptions About Ebola Preparedness Early in the US Response: A Qualitative Analysis and Lessons for the Future.

Authors:  Scott Santibañez; Philip M Polgreen; Susan E Beekmann; Mark E Rupp; Carlos Del Rio
Journal:  Health Secur       Date:  2016-09-01

9.  Survey of laboratory-acquired infections around the world in biosafety level 3 and 4 laboratories.

Authors:  N Wurtz; A Papa; M Hukic; A Di Caro; I Leparc-Goffart; E Leroy; M P Landini; Z Sekeyova; J S Dumler; D Bădescu; N Busquets; A Calistri; C Parolin; G Palù; I Christova; M Maurin; B La Scola; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-05-27       Impact factor: 3.267

10.  Low-incidence, high-consequence pathogens.

Authors:  Ermias D Belay; Stephan S Monroe
Journal:  Emerg Infect Dis       Date:  2014-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.